Hosted on MSN9d
Wall Street Analysts See a 31.33% Upside in Design Therapeutics (DSGN): Can the Stock Really Move This High?Design Therapeutics, Inc. (DSGN) closed the last trading session at $5.33, gaining 42.9% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback